a year ago
TNXP
AnalystsJames MolloyJames Molloy's Stock Forecasts
AnalystsJames Molloy
Analyst Ranking
Bottom 3%
#4851 out of 4974 analysts
Average Return
-38.89%
Win Rate
21%9 out of 42
Risk vs Reward
Poor
Good
James Molloy's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Soligenix IncSNGX | +118.05% | $1.33 | $2.90 | 2025-07-16 - 2025-08-08 | Strong Buy |
Aquestive Therapeutics IncAQST | +82.86% | $0.88 | $1.60 | 2022-11-04 - 2023-11-03 | Strong Buy |
Acurx Pharmaceuticals IncACXP | +67.33% | $60.00 | $100.40 | 2022-10-20 - 2023-10-19 | Strong Buy |
Talphera IncTLPH | +54.73% | $0.55 | $0.85 | 2023-10-02 - 2024-10-01 | Strong Buy |
Abeona Therapeutics IncABEO | +29.50% | $3.22 | $4.17 | 2023-05-24 - 2024-05-23 | Strong Buy |
James Molloy Analyst Color
Get additional color on James Molloy's coverage of popular stocks
James Molloy's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Soligenix IncSNGX | 1 | Strong Buy | $6.00 | +106.90% | Maintains | 25 days ago |
Igc Pharma IncIGC | 2 | Strong Buy | $3.50 | +929.41% | Reiterates | 5 months ago |
Intensity Therapeutics IncINTS | 1 | Strong Buy | $8.50 | +3,048.15% | Initiates Coverage On | 7 months ago |
Vtv Therapeutics IncVTVT | 1 | Strong Buy | $35.00 | +150.00% | Initiates Coverage On | 8 months ago |
Geovax Labs IncGOVX | 1 | Strong Buy | $15.00 | +2,109.13% | Initiates Coverage On | 9 months ago |
Inmune Bio IncINMB | 1 | Strong Buy | $20.00 | +681.25% | Initiates Coverage On | 10 months ago |
Scilex Holding CoSCLX | 1 | Strong Buy | $490.00 | +3,017.05% | Initiates Coverage On | 10 months ago |
Tonix Pharmaceuticals Holding CorpTNXP | 7 | Strong Buy | $1,100.00 | N/A | Maintains | a year ago |
Pedevco CorpPED | 1 | Strong Buy | $1.75 | N/A | Initiates Coverage On | a year ago |
Pyxis Tankers IncPXS | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | a year ago |
Opus Genetics IncIRD | 2 | Strong Buy | $20.00 | N/A | Maintains | a year ago |
Xortx Therapeutics IncXRTX | 2 | Strong Buy | $14.00 | N/A | Maintains | 2 years ago |
Synlogic IncSYBX | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 2 years ago |
Talphera IncTLPH | 1 | Strong Buy | $4.25 | N/A | Initiates Coverage On | 2 years ago |
Barinthus Biotherapeutics PLCBRNS | 1 | Strong Buy | $12.00 | N/A | Initiates Coverage On | 2 years ago |
Neurosense Therapeutics LtdNRSN | 1 | Strong Buy | $7.50 | N/A | Initiates Coverage On | 2 years ago |
Alimera Sciences IncALIM | 2 | Strong Buy | $8.00 | N/A | Upgrades | 2 years ago |
Abeona Therapeutics IncABEO | 1 | Strong Buy | $20.00 | N/A | Reiterates | 2 years ago |
Athersys IncATHXQ | 1 | Strong Buy | $5.50 | N/A | Initiates Coverage On | 2 years ago |
Sellas Life Sciences Group IncSLS | 1 | Strong Buy | $8.00 | N/A | Maintains | 3 years ago |
Aquestive Therapeutics IncAQST | 2 | Strong Buy | $7.00 | N/A | Maintains | 3 years ago |
Akari Therapeutics PLCAKTX | 1 | Strong Buy | $80.00 | N/A | Initiates Coverage On | 3 years ago |
Reviva Pharmaceuticals Holdings IncRVPH | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | 3 years ago |
Acurx Pharmaceuticals IncACXP | 1 | Strong Buy | $280.00 | N/A | Initiates Coverage On | 3 years ago |
Imunon IncIMNN | 1 | Strong Buy | $225.00 | N/A | Initiates Coverage On | 3 years ago |
Quoin Pharmaceuticals LtdQNRX | 1 | Strong Buy | $8,400.00 | N/A | Initiates Coverage On | 3 years ago |
Celularity IncCELU | 1 | Strong Buy | $150.00 | N/A | Initiates Coverage On | 3 years ago |
Pluri IncPLUR | 2 | Strong Buy | $4.00 | N/A | Maintains | 3 years ago |
Enveric Biosciences IncENVB | 1 | Strong Buy | $937.50 | N/A | Initiates Coverage On | 3 years ago |
Ampio Pharmaceuticals IncAMPE | 1 | Strong Buy | $1,350.00 | N/A | Initiates Coverage On | 3 years ago |
Entasis Therapeutics Holdings IncETTX | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Achieve Life Sciences IncACHV | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.